Form 4: Rockwell Medical Director Allen Nissenson Acquires 50,000 Shares of Common Stock

Director Allen Nissenson acquired 50,000 shares of Rockwell Medical common stock on May 20, 2025, as part of a restricted stock unit grant.

Summary

• On May 20, 2025, Allen Nissenson, a director of Rockwell Medical, Inc., acquired 50,000 shares of common stock.
• The acquisition was in the form of restricted stock units.
• These restricted stock units vest on May 20, 2026, contingent upon Nissenson's continued service to the company.
• The price per share was $0.
• Following the transaction, Nissenson directly owns 142,597 shares of Rockwell Medical common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director. The acquisition itself can be seen as a slightly positive sign, indicating confidence, but the document is primarily informational.

Positives

• The acquisition of shares by a director signals confidence in the company's future.

Future Outlook

The vesting of the restricted stock units is contingent upon the reporting person's continued service to the issuer.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, trade in their company's stock. These filings provide transparency to the market regarding insider activity.

Key Dates

Keywords

Rockwell Medical, RMTI, Allen Nissenson, Director, Stock Acquisition, Restricted Stock Units, Form 4, Beneficial Ownership